Focused Ultrasound Effects on Osteosarcoma Cell Lines

Valentina Agnese, Viviana Costa, Gian Luca Scoarughi, Cristiano Corso, Valeria Carina, Angela De Luca, Daniele Bellavia, Lavinia Raimondi, Stefania Pagani, Massimo Midiri, Giorgio Stassi, Riccardo Alessandro, Milena Fini, Gaetano Barbato, Gianluca Giavaresi

Research output: Contribution to journalArticle

Abstract

MRI guided Focused Ultrasound (MRgFUS) has shown to be effective therapeutic modality for non-invasive clinical interventions in ablating of uterine fibroids, in bone metastasis palliative treatments, and in breast, liver, and prostate cancer ablation. MRgFUS combines high intensity focused ultrasound (HIFU) with MRI images for treatment planning and real time thermometry monitoring, thus enabling non-invasive ablation of tumor tissue. Although in the literature there are several studies on the Ultrasound (US) effects on cell in culture, there is no systematic evidence of the biological effect of Magnetic Resonance guided Focused Ultrasound Surgery (MRgFUS) treatment on osteosarcoma cells, especially in lower dose regions, where tissues receive sub-lethal acoustic power. The effect of MRgFUS treatment at different levels of acoustic intensity (15.5-49 W/cm2) was investigated on Mg-63 and Saos-2 cell lines to evaluate the impact of the dissipation of acoustic energy delivered outside the focal area, in terms of cell viability and osteogenic differentiation at 24 h, 7 days, and 14 days after treatment. Results suggested that the attenuation of FUS acoustic intensities from the focal area (higher intensities) to the "far field" (lower intensities) zones might determine different osteosarcoma cell responses, which range from decrease of cell proliferation rates (from 49 W/cm2 to 38.9 W/cm2) to the selection of a subpopulation of heterogeneous and immature living cells (from 31.1 W/cm2 to 15.5 W/cm2), which can clearly preserve bone tumor cells.

Original languageEnglish
Pages (from-to)1-14
Number of pages14
JournalBioMed Research International
DOIs
Publication statusPublished - May 19 2019

Fingerprint

Osteosarcoma
Acoustics
Ultrasonics
Cells
Cell Line
Magnetic resonance imaging
Acoustic intensity
Ablation
Tumors
Thermometry
Bone
Therapeutics
Bone and Bones
Tissue
Leiomyoma
Liver Neoplasms
Palliative Care
Cell proliferation
Magnetic resonance
Neoplasms

Cite this

Focused Ultrasound Effects on Osteosarcoma Cell Lines. / Agnese, Valentina; Costa, Viviana; Scoarughi, Gian Luca; Corso, Cristiano; Carina, Valeria; De Luca, Angela; Bellavia, Daniele; Raimondi, Lavinia; Pagani, Stefania; Midiri, Massimo; Stassi, Giorgio; Alessandro, Riccardo; Fini, Milena; Barbato, Gaetano; Giavaresi, Gianluca.

In: BioMed Research International, 19.05.2019, p. 1-14.

Research output: Contribution to journalArticle

Agnese, V, Costa, V, Scoarughi, GL, Corso, C, Carina, V, De Luca, A, Bellavia, D, Raimondi, L, Pagani, S, Midiri, M, Stassi, G, Alessandro, R, Fini, M, Barbato, G & Giavaresi, G 2019, 'Focused Ultrasound Effects on Osteosarcoma Cell Lines', BioMed Research International, pp. 1-14. https://doi.org/10.1155/2019/6082304
Agnese, Valentina ; Costa, Viviana ; Scoarughi, Gian Luca ; Corso, Cristiano ; Carina, Valeria ; De Luca, Angela ; Bellavia, Daniele ; Raimondi, Lavinia ; Pagani, Stefania ; Midiri, Massimo ; Stassi, Giorgio ; Alessandro, Riccardo ; Fini, Milena ; Barbato, Gaetano ; Giavaresi, Gianluca. / Focused Ultrasound Effects on Osteosarcoma Cell Lines. In: BioMed Research International. 2019 ; pp. 1-14.
@article{2df5baf7749942469ab7f9964c0b0efe,
title = "Focused Ultrasound Effects on Osteosarcoma Cell Lines",
abstract = "MRI guided Focused Ultrasound (MRgFUS) has shown to be effective therapeutic modality for non-invasive clinical interventions in ablating of uterine fibroids, in bone metastasis palliative treatments, and in breast, liver, and prostate cancer ablation. MRgFUS combines high intensity focused ultrasound (HIFU) with MRI images for treatment planning and real time thermometry monitoring, thus enabling non-invasive ablation of tumor tissue. Although in the literature there are several studies on the Ultrasound (US) effects on cell in culture, there is no systematic evidence of the biological effect of Magnetic Resonance guided Focused Ultrasound Surgery (MRgFUS) treatment on osteosarcoma cells, especially in lower dose regions, where tissues receive sub-lethal acoustic power. The effect of MRgFUS treatment at different levels of acoustic intensity (15.5-49 W/cm2) was investigated on Mg-63 and Saos-2 cell lines to evaluate the impact of the dissipation of acoustic energy delivered outside the focal area, in terms of cell viability and osteogenic differentiation at 24 h, 7 days, and 14 days after treatment. Results suggested that the attenuation of FUS acoustic intensities from the focal area (higher intensities) to the {"}far field{"} (lower intensities) zones might determine different osteosarcoma cell responses, which range from decrease of cell proliferation rates (from 49 W/cm2 to 38.9 W/cm2) to the selection of a subpopulation of heterogeneous and immature living cells (from 31.1 W/cm2 to 15.5 W/cm2), which can clearly preserve bone tumor cells.",
author = "Valentina Agnese and Viviana Costa and Scoarughi, {Gian Luca} and Cristiano Corso and Valeria Carina and {De Luca}, Angela and Daniele Bellavia and Lavinia Raimondi and Stefania Pagani and Massimo Midiri and Giorgio Stassi and Riccardo Alessandro and Milena Fini and Gaetano Barbato and Gianluca Giavaresi",
year = "2019",
month = "5",
day = "19",
doi = "10.1155/2019/6082304",
language = "English",
pages = "1--14",
journal = "BioMed Research International",
issn = "2314-6133",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Focused Ultrasound Effects on Osteosarcoma Cell Lines

AU - Agnese, Valentina

AU - Costa, Viviana

AU - Scoarughi, Gian Luca

AU - Corso, Cristiano

AU - Carina, Valeria

AU - De Luca, Angela

AU - Bellavia, Daniele

AU - Raimondi, Lavinia

AU - Pagani, Stefania

AU - Midiri, Massimo

AU - Stassi, Giorgio

AU - Alessandro, Riccardo

AU - Fini, Milena

AU - Barbato, Gaetano

AU - Giavaresi, Gianluca

PY - 2019/5/19

Y1 - 2019/5/19

N2 - MRI guided Focused Ultrasound (MRgFUS) has shown to be effective therapeutic modality for non-invasive clinical interventions in ablating of uterine fibroids, in bone metastasis palliative treatments, and in breast, liver, and prostate cancer ablation. MRgFUS combines high intensity focused ultrasound (HIFU) with MRI images for treatment planning and real time thermometry monitoring, thus enabling non-invasive ablation of tumor tissue. Although in the literature there are several studies on the Ultrasound (US) effects on cell in culture, there is no systematic evidence of the biological effect of Magnetic Resonance guided Focused Ultrasound Surgery (MRgFUS) treatment on osteosarcoma cells, especially in lower dose regions, where tissues receive sub-lethal acoustic power. The effect of MRgFUS treatment at different levels of acoustic intensity (15.5-49 W/cm2) was investigated on Mg-63 and Saos-2 cell lines to evaluate the impact of the dissipation of acoustic energy delivered outside the focal area, in terms of cell viability and osteogenic differentiation at 24 h, 7 days, and 14 days after treatment. Results suggested that the attenuation of FUS acoustic intensities from the focal area (higher intensities) to the "far field" (lower intensities) zones might determine different osteosarcoma cell responses, which range from decrease of cell proliferation rates (from 49 W/cm2 to 38.9 W/cm2) to the selection of a subpopulation of heterogeneous and immature living cells (from 31.1 W/cm2 to 15.5 W/cm2), which can clearly preserve bone tumor cells.

AB - MRI guided Focused Ultrasound (MRgFUS) has shown to be effective therapeutic modality for non-invasive clinical interventions in ablating of uterine fibroids, in bone metastasis palliative treatments, and in breast, liver, and prostate cancer ablation. MRgFUS combines high intensity focused ultrasound (HIFU) with MRI images for treatment planning and real time thermometry monitoring, thus enabling non-invasive ablation of tumor tissue. Although in the literature there are several studies on the Ultrasound (US) effects on cell in culture, there is no systematic evidence of the biological effect of Magnetic Resonance guided Focused Ultrasound Surgery (MRgFUS) treatment on osteosarcoma cells, especially in lower dose regions, where tissues receive sub-lethal acoustic power. The effect of MRgFUS treatment at different levels of acoustic intensity (15.5-49 W/cm2) was investigated on Mg-63 and Saos-2 cell lines to evaluate the impact of the dissipation of acoustic energy delivered outside the focal area, in terms of cell viability and osteogenic differentiation at 24 h, 7 days, and 14 days after treatment. Results suggested that the attenuation of FUS acoustic intensities from the focal area (higher intensities) to the "far field" (lower intensities) zones might determine different osteosarcoma cell responses, which range from decrease of cell proliferation rates (from 49 W/cm2 to 38.9 W/cm2) to the selection of a subpopulation of heterogeneous and immature living cells (from 31.1 W/cm2 to 15.5 W/cm2), which can clearly preserve bone tumor cells.

U2 - 10.1155/2019/6082304

DO - 10.1155/2019/6082304

M3 - Article

SP - 1

EP - 14

JO - BioMed Research International

JF - BioMed Research International

SN - 2314-6133

ER -